MedTech 100 roundup: New all-time best reached

Once again, the medtech industry has soared to new heights, eclipsing its all-time best performance by the tiniest of margins.

MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (July 2) at 114.59 points, coming in just 0.01 points ahead of the 114.58-point mark set in April — previously the industry’s all-time best performance.

The new high mark also represents a 1% rise from the 113.42-point total reached last week (June 25). The industry took a strong June into July, rising nearly 7% over the past four weeks.

Having overcome some recent setbacks, medtech’s performance continues to reflect an overall rebound from the struggles brought on by the COVID-19 pandemic, too. The industry has registered a 24.1% rise from the pre-pandemic high of 92.32 (set on Feb. 19, 2020), plus an 84.4% increase from the mid-pandemic low of 62.13 (March 23, 2020).

The positive movement in medtech …

Read more
  • 0

Belluscura is back with an IPO in the U.K.

Belluscura last month filed for an initial public offering (IPO) more than three years after pulling its plans for going public in the U.K.

The London-based company with U.S. headquarters in Plano, Texas, on May 24 confirmed an issue price of approximately $24.2 million (£17.5 million) for placing on the AIM market of the London Stock Exchange.

Belluscura finished today trading at $78.22 (£56.50) per share on the London Stock Exchange. CEO Robert Rauker noted in an email to MassDevice that the IPO was oversubscribed and the company is now trading at between 20% and 24% above the IPO price.

In December 2017, the company pulled plans for its $13 million British IPO due to market condition issues, with backer Tekcapital saying that the withdrawal was due to “current market conditions and certain other enterprise investment scheme/venture capital trust requirements having not been met in the expected timeframe.”

Belluscura was established by Tekcapita…

Read more
  • 0